McFadden Michael S MS

Show results for

Unknown (12)
Metabolomics (2)
Proteomics (2)
Transcriptomics (1)

Organisms

Homo sapiens (1)
Plasmodium (1)

Repository

biostudies-arrayexpress (1)
GNPS (1)
jPOST (1)
MassIVE (1)
MetaboLights (1)

Technology Type

Mass spectrometry (1)

Instrument Platform

Agilent 6530 QTOF (2)
GCMS-QP2010 Plus (Shimadzu) (1)

Publication Date

2020 (2)
2011 (1)
2024 (1)
2018 (1)

CHEBI ID

CHEBI:138264 (1)
CHEBI:72688 (1)
CHEBI:32943 (1)
CHEBI:46050 (1)
CHEBI:87978 (1)
CHEBI:32927 (1)
CHEBI:36020 (1)
CHEBI:4139 (1)
CHEBI:17317 (1)
CHEBI:28897 (1)
CHEBI:28817 (1)
CHEBI:22660 (1)
CHEBI:12936 (1)
CHEBI:17634 (1)
CHEBI:78697 (1)
CHEBI:78736 (1)
CHEBI:10642 (1)
CHEBI:22652 (1)
CHEBI:16988 (1)
CHEBI:17822 (1)
CHEBI:17057 (1)
CHEBI:17924 (1)
CHEBI:32528 (1)
CHEBI:28790 (1)
CHEBI:17148 (1)
CHEBI:17568 (1)
CHEBI:16704 (1)
CHEBI:78679 (1)
CHEBI:17992 (1)
CHEBI:14314 (1)

Metabolite Name

D-sorbitol-1-13C m/z_320 (alt. m/z quant.) (1)
D-sorbitol-1-13C m/z_319 (alt. m/z quant.) (1)
D-sorbitol-1-13C m/z_206 (alt. m/z quant.) (1)
D-sorbitol-1-13C m/z_205 (alt. m/z quant.) (1)
D-sorbitol 13C6 m/z_322 (alt. m/z quant.) (1)
Saturated_Guanine manual (1)
Unknown_17.908, 1332, m/z 247 (1)
5-Hydroxyindole-3-acetic acid, 3 TMS, 35.49, 2212 (1)
Unkown_32.762, 2047, m/z 132 (1)
Mannitol, 6 TMS, 30.6, 1915 (alt. m/z quant. high dynamic range) (1)
D-(+)-Glucose, 5 TMS, MEOX, 30.38, 1902 (alt. m/z quant. high dynamic range) (1)
D-(+)-Galactose, 5 TMS, MEOX, 29.94, 1880 (alt. m/z quant. high dynamic range) (1)
Glutamic acid, 3 TMS, 24.79, 1623 (alt. m/z quant. high dynamic range) (1)
Serotonin, x TMS, 39.11, 2470 (alt. m/z quant. high dynamic range) (1)
D-(+)-Turanose, 7 TMS, 42.29, 2702 (1)
L-Lysine, 3 TMS, 26.54, 1712 (1)
L-Leucine, 2 TMS, 16.74, 1274 (1)
L-Leucine, 1 TMS, 13.8, 1155 (1)
Serine, 2 TMS, 16.43, 1260 (1)
Unknown_38.398, 2421, m/z 387 (1)
Benzoic acid, 1 TMS, 16.26, 1254 (1)
Unknown_53.63, 3702, m/z 311 (1)
Unknown_51.603, 3505, m/z283 (1)
Unknown_46.866, 3064, m/z 169 (1)
Unknown_48.018, 3163, m/z 329 (1)
Unknown_46.848, 3063, m/z 169 (1)
Unknown_44.338, 2848, m/z 103 (1)
Unknown_44.010, 2820, m/z 169 (1)
Unknown_44.002, 2820, m/z 131 (1)
Unknown_43.658, 2792, m/z 126 (1)

Study type

Methylation profiling by array (1)

Release Date

2021 (4)
2022 (3)
2023 (2)
2011 (1)
2025 (1)
2024 (1)
2020 (1)

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

Survival, gene and metabolite responses of Litoria verreauxii alpina frogs to fungal disease chytridiomycosis

The fungal skin disease chytridiomycosis has caused the devastating decline and extinction of hundreds of amphibian species globally, yet the potential for evolving resistance, and the underlying pathophysiological mechanisms remain poorly understood. We exposed 406 naïve, captive-raised alpine tree...

2018-01-09 | MTBLS457 | MetaboLights

Bile acid dehydroxylation by the gut microbiome

A metabolic pathway for bile acid dehydroxylation by the gut microbiome

ORGANISM(S): Clostridium (ncbitaxon:1485)

2020-03-02 | MSV000085048 | MassIVE

DNA methylation profiling of somatic tissues from normal and trisomic fetuses

The DNA methylation profiles in normal and abnormal fetal development were investigated using Illumina GoldenGate Methylation Cancer Panel I. DNA methylation status of 1505 CpG dinucleotides located in the regulatory regions of 807 genes was measured in 5 somatic tissues (brain, kidney, lung, muscle...

ORGANISM(S): Homo sapiens

2011-05-06 | E-GEOD-25283 | biostudies-arrayexpress

GNPS - Bile acid dehydroxylation by the gut microbiome

A metabolic pathway for bile acid dehydroxylation by the gut microbiome

ORGANISM(S): Clostridium (ncbitaxon:1485)

2020-03-02 | MSV000085048 | GNPS

WEHI991 drug target identification by DIA Solvent PISA

Here we demonstrate PfSTART1 engagement by WEHI991 in the P. falciparum proteome using organic solvent-based Proteome Integral Solubility Alteration (Solvent PISA) assay coupled with Data Independent Acquisition Mass Spectrometry (DIA-MS).

ORGANISM(S): Plasmodium (plasmodium)

2024-05-01 | PXD048262 | JPOST Repository

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC7884931 | biostudies-literature

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8084355 | biostudies-literature

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8830904 | biostudies-literature

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.